FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

400488003: Glatiramer acetate 20mg/vial injection solution (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1768408013 Glatiramer acetate 20mg/vial injection solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1779723011 Glatiramer acetate 20mg/vial injection solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1787245014 Glatiramer acetate 20mg/vial injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4722211000005115 glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas Is a Product containing glatiramer (medicinal product) false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sirolimus (substance) false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glatiramer (substance) false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. biologisk middel false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas Has manufactured dose form injektionsvæske false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glatiramer acetate (substance) false Inferred relationship Some
    glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas Has manufactured dose form Solution for injection false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start